Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Fluorodeoxyglucose F18 × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Oropharyngeal Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Anus Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Neoplasms, Unknown Primary 1 Melanoma 1 Lymphoma, Mantle-Cell 1

Interventions

atezolizumab 3 Etoposide 2 Cisplatin 2 zimberelimab 1 tivozanib 1 durvalumab 1 cabozantinib 1 belinostat 1 Temozolomide 1 Standard of Care 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Capecitabine 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡